11.59
Schlusskurs vom Vortag:
$11.59
Offen:
$11.56
24-Stunden-Volumen:
57,084
Relative Volume:
0.26
Marktkapitalisierung:
$129.53M
Einnahmen:
$346.10M
Nettoeinkommen (Verlust:
$-20.02M
KGV:
-6.3556
EPS:
-1.8228
Netto-Cashflow:
$-1.47M
1W Leistung:
-4.04%
1M Leistung:
+5.44%
6M Leistung:
+7.99%
1J Leistung:
-15.11%
Medifast Inc Stock (MED) Company Profile
Firmenname
Medifast Inc
Sektor
Branche
Telefon
(410) 581-8042
Adresse
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, HRB, FTDR, MMED
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MED
Medifast Inc
|
11.59 | 129.58M | 346.10M | -20.02M | -1.47M | -1.8228 |
|
ROL
Rollins Inc
|
36.38 | 17.57B | 3.84B | 529.30M | 621.14M | 1.0945 |
|
SCI
Service Corp International
|
83.10 | 11.50B | 4.33B | 535.79M | 486.05M | 3.79 |
|
HRB
H R Block Inc
|
53.40 | 6.87B | 3.91B | 736.10M | 760.88M | 5.6238 |
|
FTDR
Frontdoor Inc
|
85.11 | 5.89B | 2.12B | 260.00M | 385.00M | 3.5067 |
|
MMED
Medifast Inc
|
20.12 | 5.81B | 0 | 0 | 0 | 0.00 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Hochstufung | DA Davidson | Underperform → Neutral |
| 2024-06-05 | Herabstufung | DA Davidson | Neutral → Underperform |
| 2023-10-13 | Eingeleitet | Stephens | Equal-Weight |
| 2022-11-04 | Herabstufung | DA Davidson | Buy → Neutral |
| 2022-08-04 | Herabstufung | Jefferies | Buy → Hold |
| 2021-01-25 | Hochstufung | Jefferies | Hold → Buy |
| 2020-11-05 | Hochstufung | DA Davidson | Neutral → Buy |
| 2020-06-25 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-27 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-08 | Herabstufung | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | Eingeleitet | Jefferies | Buy |
| 2018-11-08 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-03-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2017-09-15 | Bestätigt | DA Davidson | Buy |
| 2016-08-04 | Bestätigt | Wunderlich | Hold |
| 2016-01-11 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-11-30 | Herabstufung | Sidoti | Buy → Neutral |
| 2015-10-05 | Hochstufung | Sidoti | Neutral → Buy |
| 2014-11-07 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2014-08-08 | Bestätigt | Imperial Capital | Outperform |
| 2014-04-23 | Bestätigt | Imperial Capital | Outperform |
| 2013-09-06 | Eingeleitet | Imperial Capital | Outperform |
| 2012-11-06 | Bestätigt | Northland Securities | Outperform |
| 2012-07-27 | Hochstufung | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | Herabstufung | Standpoint Research | Buy → Hold |
| 2012-01-30 | Eingeleitet | Standpoint Research | Buy |
Alle ansehen
Medifast Inc Aktie (MED) Neueste Nachrichten
Medifast (NYSE:MED) Cut to Hold at Zacks Research - MarketBeat
Medifast (MED): Charles Schwab Investment Management reports 3.6% ownership stake - stocktitan.net
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth? - Yahoo Finance
Medifast’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Medifast (MED) Q2 2026 Earnings Call Transcript - aol.com
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround? - TradingView
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building? - TradingView
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround? - TradingView
Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade) - Seeking Alpha
Medifast (MED) Stock Rally Leans On Cash As Coach Base Shrinks - Sahm
Why Medifast (MED) Stock Is Trading Up Today - Barchart.com
Medifast rebrands flagship diet product amid pressure from GLP-1s - The Business Journals
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves - Yahoo Finance
Medifast, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... By GuruFocus - Investing.com Canada
$Medifast (MED.US)$ - Moomoo
Medifast Inc (MED) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trilivy and ... - Yahoo Finance
Medifast Q2 loss widens as coach base shrinks by 48.7% - scanx.trade
Medifast Q2 Earnings Call Highlights - MarketBeat
Medifast, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:MED) 2026-08-03 - Seeking Alpha
Earnings call transcript: Medifast tops Q2 2026 estimates, shares jump after hours - Investing.com
Medifast (NYSE:MED) Updates FY 2026 Earnings Guidance - MarketBeat
Medifast (NYSE:MED) Updates Q3 2026 Earnings Guidance - MarketBeat
11 Consumer Staples Stocks Moving In Monday's After-Market Session - Benzinga
MEDIFAST INC 2026: Revenue $76.38M, EPS ($0.28) — 10-Q Summary - TradingView
Medifast: Q2 Earnings Snapshot - aol.com
Medifast Q2 revenue falls 28 percent to $76.4 million - Quiver Quantitative
Medifast Announces Second Quarter 2026 Financial Results - marketscreener.com
Press Release: Medifast Announces Second Quarter 2026 Financial Results - Moomoo
Medifast Q2 2026 slides: Trilivy brand launch, coach productivity gains By Investing.com - Investing.com Canada
Earnings To Watch: Medifast (MED) Reports Q2 Results Tomorrow - Yahoo Finance
Medifast Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Medifast Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
BlackRock discloses 2.9% Medifast (NYSE: MED) ownership stake - stocktitan.net
Medifast Stock to Post Q2 Earnings: What Investors Should Know - Yahoo Finance
Medifast Inc (MED) Cash Flow - TradingKey
Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Medifast (MED) to Release Quarterly Earnings on Monday - MarketBeat
Medifast Inc (MED) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lido Advisors LLC Decreases Stock Holdings in Medifast Inc $MED - MarketBeat
MED|Medifast Inc|Price:9.680|Chg%:+0.220 - TradingKey
Medifast Inc (MED) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Medifast Inc (MED) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MED|Medifast Inc|Price:9.930|Chg%:+0.250 - TradingKey
Medifast Inc (MED) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Medifast Inc (0K05) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Medifast Inc (0K05) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Medifast Inc (0K05) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Medifast Inc (MED) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Medifast Inc (MED) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Medifast Inc (MED) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Finanzdaten der Medifast Inc-Aktie (MED)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):